| ILMN Snapshot | |
|---|---|
| Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California. | |
| VALUATION DATA | |
| Market Capitalization | $19,809,839,000 | Price to Sales | 12.00 |
| Earnings per Share | $-7.3400 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $121.0500 |
| 52 Week High | $4.493 |
| 52 Week Low | $3.523 |
| 50-Day Moving Average | $4.762 |
| 200-Day Moving Average | $-35.27 |
| All data are from Alpha Vantage as of today. For more infomation on ILMN see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search